Post-IPO Equity - BioCryst Pharmaceuticals - Aug 13, 2014 Funding Round Profile - Cointime

Bitcoin $79,036.48 +3.06%
Ethereum $3,171.75 +3.69%
BNB $628.86 -0.70%
Optimism $1.66 -0.98%
Arbitrum $0.62 +1.18%
Solana $205.71 +1.70%
Polygon $0.40 +3.49%
Cosmos $4.94 +3.42%
Avalanche $31.56 +6.73%

Bitcoin $79,036.48 +3.06%
Ethereum $3,171.75 +3.69%
BNB $628.86 -0.70%
Optimism $1.66 -0.98%
Arbitrum $0.62 +1.18%
Solana $205.71 +1.70%
Polygon $0.40 +3.49%
Cosmos $4.94 +3.42%
Avalanche $31.56 +6.73%

BioCryst Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 4.09M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
National Institutes of Health	-	-	-	Detail